Skip to main content
RenovoRx, Inc. (RNXT)
NASDAQ: RNXT · Real-Time Price · USD
0.809
+0.019 (2.38%)
Mar 9, 2026, 1:07 PM EDT - Market open

RenovoRx Revenue

RenovoRx had revenue of $266.00K in the quarter ending September 30, 2025. This brings the company's revenue in the last twelve months to $928.00K. In the year 2024, RenovoRx had annual revenue of $43.00K.

Revenue (ttm)
$928.00K
Revenue Growth
n/a
P/S Ratio
31.21
Revenue / Employee
$92,800
Employees
10
Market Cap
29.65M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202443.00K--
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Kyntra Bio 8.30M
Cue Biopharma 7.10M
Dyadic International 3.34M
Werewolf Therapeutics 1.14M
IGC Pharma 1.11M
Revenue Rankings

RNXT News

More News